InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Gill Simba. Insider active across 2 companies, notably Foghorn Therapeutics Inc.. Aggregated, 6 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €404. Activity tracked since 12 September 2022. The latest transaction was filed on 8 May 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
GILL SIMBA is a declarant linked to Evelo Biosciences, Inc., where he is President & CEO, and to Foghorn Therapeutics Inc., where he is Director. He has 6 filings in total, and across the 6 recent filings tracked from 2022-09-14 to 2023-11-08, the sell amount is EUR 404 and the most common transaction nature is option exercise.